HOPE-3 trial suggests that statin therapy is beneficial even in low-risk populations
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Prof. Alberto Zambon MD, PhD, FAHA
Prof. Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Prof. Thomas Lüscher, MD